About this trial

This study aim to find the best option for children having cancer who develop low immunity state due to chemotherapy

Eligibility criteria

Qualifiers

Age 1-16 years

any Gender

Febrile neutropenia

diagnosed case of solid or hematological malignancy

Disqualifiers

Non-neutropenic fever

already received G-CSF or antibiotics before presenting to hospital

any other cause of neutropenia

Trial design

Treatments tested in this trial

  • G-CSF
  • Antibiotics only

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

King Edward Medical University

Lead sponsor

University of Child Health Sciences and Children's Hospital, Lahore

Collaborator